In the presence of Omicron, a British scientist who led the research to create the vaccine Oxford and AstraZeneca, stated that you could create “very fast” a new inoculation against the South African variant, detected in a few days and classified as “worrying” by World Health Organization (WHO).
It’s about the teacher Andrew Pollard, director of the Oxford Vaccine Group, who further considered that it is “highly unlikely” that this new variant spreads strongly among the already vaccinated population “as it was seen last year” with the variant Delta.
However, he assured that if that happened “it would be possible to act very quickly” because “The development processes of a new vaccine are getting better and better.”
Speaking to the BBC, Pollard affirmed that the current vaccines should work against the new variant, although he considered that that can only be confirmed in the next few weeks, according to the news agency AFP.
Ómicron: Where were cases found?
In Europe, two cases related to the omicron variant have been identified so far, one in Belgium and another in Germany.
However, the authorities of the Netherlands they are investigating 61 people from South Africa who tested positive for coronavirus, it has not yet been confirmed whether they carry the new variant. Ómicron was also detected in Malawi, Israel, Botswana and Hong Kong.
Meanwhile, the WHO described Friday as “worrying” to the new strain before its “high number of mutations” and propagation capacity.
In a statement, AstraZeneca declared to have “developed, in close collaboration with the University of Oxford, a platform that allows us to respond quickly to the vaccination of new variants that may appear.”
The British pharmaceutical company stated that “is conducting research at the sites where the variant was identified” Omicron.
Manufacturers of other vaccines such as Pfizer / BioNTech, Modern and Novavax They also showed their confidence in their ability to combat the new variant.